Wendy future of retail top

Soliqua 100/33

Sanofi launches Soliqua 100/33 insulin pen

Sanofi launches Soliqua 100/33 insulin pen

PARIS — Sanofi has released Soliqua 100/33, an insulin injection for type 2 diabetes, to U.S. pharmacies. The company said Wednesday that Soliqua 100/33 (insulin glargine 100 units/ml and lixisenatide 33 mcg/ml) comes in a single, prefilled SoloStar pen with a dosage range of 15 to 60 units and two starting doses to support patients’

Centrum 7/6  banner